40
Participants
Start Date
March 2, 2021
Primary Completion Date
October 27, 2021
Study Completion Date
February 25, 2022
IL-6R Monoclonal Antibody Injection 4mg/kg
IL-6R Monoclonal Antibody Injection 4mg/kg i.v.,single use
IL-6R Monoclonal Antibody Injection 6mg/kg
IL-6R Monoclonal Antibody Injection 6mg/kg i.v. , single use
IL-6R Monoclonal Antibody Injection 8mg/kg
IL-6R Monoclonal Antibody Injection 8mg/kg i.v. , single use
Tocilizumab Injection 8mg/kg
Tocilizumab Injection 8mg/kg i.v., single use
Affiliated Hospital of Hebei University, Baoding
Peking University People's Hospital, Beijing
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Pingxiang City People's Hospital, Pingxiang
Peking University Shenzhen Hospital, Shenzhen
Beijing VDJBio Co., LTD.
INDUSTRY